Literature DB >> 10772722

Synthesis and biological activity of a novel class of purine nucleoside phosphorylase inhibitors.

P E Morris1, A J Elliott, S P Walton, C H Williams, J A Montgomery.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10772722     DOI： 10.1080/15257770008033016

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN： 1525-7770            Impact factor:   1.381


× No keyword cloud information.
  6 in total

1.  A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).

Authors:  Varsha Gandhi; John M Kilpatrick; William Plunkett; Mary Ayres; Leigh Harman; Min Du; Shanta Bantia; Jan Davisson; William G Wierda; Stefan Faderl; Hagop Kantarjian; Deborah Thomas
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

2.  Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.

Authors:  Florian C Schrader; Serghei Glinca; Julia M Sattler; Hans-Martin Dahse; Gustavo A Afanador; Sean T Prigge; Michael Lanzer; Ann-Kristin Mueller; Gerhard Klebe; Martin Schlitzer
Journal:  ChemMedChem       Date:  2013-01-22       Impact factor: 3.466

Review 3.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

4.  Efficient solution-phase synthesis of 4,5,7-trisubstituted pyrrolo[3,2-d]pyrimidines.

Authors:  Weihe Zhang; Jing Liu; Michael A Stashko; Xiaodong Wang
Journal:  ACS Comb Sci       Date:  2012-12-05       Impact factor: 3.784

5.  Crystal structure of Escherichia coli purine nucleoside phosphorylase complexed with acyclovir.

Authors:  Vladimir I Timofeev; Nadezhda E Zhukhlistova; Yuliya A Abramchik; Tatiana I Muravieva; Roman S Esipov; Inna P Kuranova
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-06-26       Impact factor: 1.056

Review 6.  Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review.

Authors:  Shinichi Makita; Akiko Miyagi Maeshima; Dai Maruyama; Koji Izutsu; Kensei Tobinai
Journal:  Onco Targets Ther       Date:  2018-04-20       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.